Biotechnology - Roche

Filter

Current filters:

Roche

Popular Filters

1 to 25 of 136 results

Roche continues spending spree, with acquisition of French biotech firm Trophos

Roche continues spending spree, with acquisition of French biotech firm Trophos

16-01-2015

Continuing its recent spate of deal-making, Swiss pharma giant Roche has agreed to acquire Trophos, a…

BiotechnologyMergers & AcquisitionsolesoximeRare diseasesRocheSwitzerlandTrophos

23andMe and Genentech in deal to analyze genomic data for Parkinson's disease

06-01-2015

23andMe, the leading personal genetics company, and Genentech, a subsidiary of Swiss pharma giant Roche,…

23andMeBiotechnologyGenentechNeurologicalResearchRoche

Phylogica inks $142 million license deal with Genentech

Phylogica inks $142 million license deal with Genentech

22-12-2014

Australian drug discovery firm Phylogica has extended its collaboration with Genentech, the biotech subsidiary…

Antibiotics and Infectious diseasesAustraliaBiotechnologyGenentechLicensingPhylogicaResearchRoche

Roche shares fall sharply on disappointing Ph III MARIANNE study

Roche shares fall sharply on disappointing Ph III MARIANNE study

22-12-2014

Swiss pharma major Roche saw its shares plunge 6.4% to 270.40 Swiss francs on Friday following release…

BiotechnologyGenentechHerceptinKadcylaOncologyPerjetaRoche

Bina Technologies is acquired by Roche

20-12-2014

Swiss pharma giant Roche has acquired Bina Technologies, a privately held company based in Redwood City,…

Bina TechnologiesBiotechnologyMergers & AcquisitionsRoche

Roche to acquire Austrian next-generation antibody firm Dutalys

Roche to acquire Austrian next-generation antibody firm Dutalys

19-12-2014

Swiss pharma giant Roche has agreed to acquire Dutalys, a privately held biotechnology company based…

BiotechnologyDutalysDutaMabMergers & AcquisitionsOncologyRoche

Genentech files NDA for cobimetinib with Zelboraf in advanced melanoma

Genentech files NDA for cobimetinib with Zelboraf in advanced melanoma

15-12-2014

Genentech, the US biotech subsidiary of Swiss Pharma major Roche Group, has submitted a New Drug Application…

BiotechnologycobimetinibExelixisGenentechOncologyRegulationRocheUSAZelboraf

Plans unveiled for Singapore’s biologics manufacturing industry

Plans unveiled for Singapore’s biologics manufacturing industry

13-12-2014

The Singapore Workforce Development Agency (WDA), Singapore Economic Development Board (EDB) and Biopharmaceutical…

AbbVieAmgenBaxterBiotechnologyGlaxoSmithKlineLonzaNovartisProductionRocheSingapore

Yet another indication for Roche’s blockbuster Avastin from FDA

16-11-2014

The US Food and Drug Administration on Friday approved Avastin (bevacizumab) solution for intravenous…

AvastinBiotechnologyEli LillyGemzarGenentechOncologyRegulationRocheUSA

NewLink Genetics out-licenses NLG919 to Genentech

NewLink Genetics out-licenses NLG919 to Genentech

20-10-2014

US biotech firm NewLink Genetics saw its share price rocket 21.2% in morning trading today, after it…

BiotechnologyGenentechGlobalLicensingNewLink GeneticsNLG919OncologyRoche

Eylea beats Avastin and Lucentis for visual acuity in DME patients

Eylea beats Avastin and Lucentis for visual acuity in DME patients

19-10-2014

US biotech firm Regeneron Pharmaceuticals and partner Germany’s Bayer saw their shares leap 8.5% to…

AvastinBayerBiotechnologyEyleaGenentechLucentisNovartisOphthalmicsRegeneron PharmaceuticalsResearchRoche

Russia’s Generium to establish MabThera analogue production

16-10-2014

Generium Group of Companies, one of Russia’s largest producers of innovative drugs, has commissioned…

BiosimilarsBiotechnologyGeneriumMabTheraOncologyProductionRocheRussia

Roche acquires exclusive rights to AbVitro's extension-based target enrichment technology

Roche acquires exclusive rights to AbVitro's extension-based target enrichment technology

09-10-2014

Swiss drug major Roche has acquired exclusive rights to a primer extension-based target enrichment technology…

AbVitroBiotechnologyLicensingRocheSwitzerland

Analysis of Roche’s InterMune acquisition

Analysis of Roche’s InterMune acquisition

28-08-2014

The acquisition of InterMune gives Swiss drug major Roche a substantial opportunity, owing to the Breakthrough…

BiotechnologyIdiopathic pulmonary fibrosisInterMuneMergers & AcquisitionspirfenidonePulmozymeRespiratory and PulmonaryRocheSwitzerlandXolair

Roche to partner with the Garvan Institute in genomics research

Roche to partner with the Garvan Institute in genomics research

20-08-2014

Swiss drug major Roche and the Garvan Institute of Medical Research are to collaborate in the development…

AustraliaBiotechnologyDNA sequencingGarvan InstituteGeneticsGenomics technologiesJohn MattickResearchRocheSwitzerland

Gilead gets favorable ruling in Roche arbitration

Gilead gets favorable ruling in Roche arbitration

17-08-2014

US biotech major Gilead Sciences said on Friday in a Security and Exchange Commission filing that an…

Anti-viralsArbitrationBiotechnologyBusiness FinanceBusiness FinanceGilead SciencesLegalPatentsPharmassetRocheSovaldiUSA

Genentech files sBLA for Lucentis for diabetic retinopathy

09-08-2014

Genentech, the biotech subsidiary of Swiss pharma major Roche, has submitted a supplemental Biologics…

BiotechnologyGenentechLucentisOphthalmicsRegulationRocheUSA

Roche to acquire Denmark’s Santaris Pharma

Roche to acquire Denmark’s Santaris Pharma

05-08-2014

Continuing on its path of strategic rather than mega transactions, Swiss pharma major Roche yesterday…

BiotechnologyMergers & AcquisitionsRocheSantaris PharmaSwitzerland

1 to 25 of 136 results

Back to top